News of Note—Attune Medical bags $10M; Abbott debuts neurostimulator for complex regional pain syndrome


> Attune Medical raised $10 million in series C financing for its esophageal temperature management devices. Release

> Abbott launched a new neurostimulator, the Proclaim DRG system, which treats complex regional pain syndrome of the lower limbs by stimulating the dorsal root ganglion. Release

> One Drop unveiled its diabetes management program, based on its wireless blood glucose monitoring system, which it plans to launch in 2018. Release | Read more about One Drop


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Daré Bioscience added a microchip-based implant to its pipeline and reported data from a pre-pivotal study of a hormone-free contraceptive ring.